Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LENZ Therapeutics, Inc. | Chief Medical Officer | Common Stock | 99.6K | $406K | $4.08 | Mar 21, 2024 | Direct |
LENZ Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 80.1K | Jan 9, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LENZ | LENZ Therapeutics, Inc. | Jan 9, 2025 | 1 | $0 | 4 | Jan 13, 2025 | Chief Medical Officer |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 3 | $0 | 4 | Mar 25, 2024 | Chief Medical Officer |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 0 | $0 | 3 | Mar 25, 2024 | Chief Medical Officer |